Corcept (CORT) beats on both earnings and revenues in the second quarter of 2021. The company maintains the revenue guidance for 2021.
Good day, thank you for standing by and welcome to the Corcept Therapeutics Conference Call. Today, we issued a press release announcing our financial results for the second quarter and providing a corporate update.
Corcept (CORT) delivered earnings and revenue surprises of 50.00% and 6.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?